leisure time -WSS

leisure time

author：Wikipedia 2025-09-04 22:03:06 - browse：69587

A sign of Gilead Sciences sits in front of its headquarter and next to a pedestrian crossing sign — health coverage from STAT — Justin Sullivan/Getty Images

The assault on the development of new lifesaving therapies continues apace. Recently, the First Appellate Division of California Appeals held that companies not only have to defend products they have developed and marketed, but also those they have not.

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage. In the years that followed, the company invested in research leading to additional TDF-based regimens critical to the fight against HIV. It had also done preliminary work on a similar but different drug — tenofovir alafenamide fumarate (TAF) — for which it had early, although not definitive, evidence for safety and efficacy.

Ultimately, this medicine was shown to have a better side effect profile than TDF. Starting in 2018, plaintiffs began suing Gilead for negligently failing to develop TAF earlier, on the theory that it wanted to protect the profits from TDF. Now, the California court has agreed to let the suit proceed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： A daunting task: navigating dual Medicare, Medicaid eligibility

focus

Wikipedia

WSS

Physician executives need more than on

Surge of respiratory disease in China has likely explanation

Poor hospice wound care hurts patients and families

Senate panel eyes new effort on drug shortages

Surge of respiratory disease in China has likely explanation

Why age limits for politicians are a terrible idea

hotspot

leisure time

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

Morphosys mixed study results for blood cancer drug

BioMarin wins approval for gene therapy to treat hemophilia A

Surge of respiratory disease in China has likely explanation

ChatGPT in medicine: STAT answers readers' burning questions

Why age limits for politicians are a terrible idea

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Surge of respiratory disease in China has likely explanation

Wildfire smoke exposes gaps in outdoor worker protections

Bristol 'take

leisure time

A virus, fished out of a lake, may have saved a man’s life

Chemotherapy drug shortage eases slightly but still widespread

World's first CRISPR

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

In key trial, Verve's treatment lowers cholesterol levels in patients

Sana to lay off nearly a third of staff, de

focus

leisure time

Wikipedia

explore